Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

  • You have access
    (S)-1-((S)-2-{[1-(4-Amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an Orally Available Selective Interleukin (IL)-Converting Enzyme/Caspase-1 Inhibitor, Exhibits Potent Anti-Inflammatory Activities by Inhibiting the Release of IL-1β and IL-18
    Woods Wannamaker, Robert Davies, Mark Namchuk, John Pollard, Pamella Ford, George Ku, Caroline Decker, Paul Charifson, Peter Weber, Ursula A. Germann, Keisuke Kuida and John C. R. Randle
    Journal of Pharmacology and Experimental Therapeutics May 2007, 321 (2) 509-516; DOI: https://doi.org/10.1124/jpet.106.111344
  • You have access
    Inhibition of Lipopolysaccharide-Induced Prostaglandin E2 Production and Inflammation by the Na+/H+ Exchanger Inhibitors
    Fumitaka Kamachi, Hyun Seung Ban, Noriyasu Hirasawa and Kazuo Ohuchi
    Journal of Pharmacology and Experimental Therapeutics April 2007, 321 (1) 345-352; DOI: https://doi.org/10.1124/jpet.106.116251
  • You have access
    Anti-Inflammatory Effects of 4-Phenyl-3-butenoic Acid and 5-(Acetylamino)-4-oxo-6-phenyl-2-hexenoic Acid Methyl Ester, Potential Inhibitors of Neuropeptide Bioactivation
    John D. Bauer, Jeffrey A. Sunman, Michael S. Foster, Jeremy R. Thompson, Alison A. Ogonowski, Stephen J. Cutler, Sheldon W. May and Stanley H. Pollock
    Journal of Pharmacology and Experimental Therapeutics March 2007, 320 (3) 1171-1177; DOI: https://doi.org/10.1124/jpet.106.110940
  • You have access
    Neutral Endopeptidase Up-Regulation in Isolated Human Umbilical Artery: Involvement in Desensitization of Bradykinin-Induced Vasoconstrictor Effects
    Facundo Germán Pelorosso, Ana Verónica Halperin, Alejandro Martín Palma, Wanda Nowak, Andrea Emilse Errasti and Rodolfo Pedro Rothlin
    Journal of Pharmacology and Experimental Therapeutics February 2007, 320 (2) 713-720; DOI: https://doi.org/10.1124/jpet.106.113381
  • You have access
    Sphingosine 1-Phosphate Causes Airway Hyper-Reactivity by Rho-Mediated Myosin Phosphatase Inactivation
    Hiroaki Kume, Naoya Takeda, Tetsuya Oguma, Satoru Ito, Masashi Kondo, Yasushi Ito and Kaoru Shimokata
    Journal of Pharmacology and Experimental Therapeutics February 2007, 320 (2) 766-773; DOI: https://doi.org/10.1124/jpet.106.110718
  • You have access
    Regulation of Lipopolysaccharide-Induced Inducible Nitric-Oxide Synthase Expression through the Nuclear Factor-κB Pathway and Interferon-β/Tyrosine Kinase 2/Janus Tyrosine Kinase 2-Signal Transducer and Activator of Transcription-1 Signaling Cascades by 2-Naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (THI 53), a New Synthetic Isoquinoline Alkaloid
    Hye Jung Kim, Konstantin Tsoyi, Ja Myung Heo, Young Jin Kang, Min Kyu Park, Young Soo Lee, Jae Heun Lee, Han Geuk Seo, Hye Sook Yun-Choi and Ki Churl Chang
    Journal of Pharmacology and Experimental Therapeutics February 2007, 320 (2) 782-789; DOI: https://doi.org/10.1124/jpet.106.112052
  • You have access
    Cocaine Dependence and Acute Cocaine Induce Decreases of Monocyte Proinflammatory Cytokine Expression across the Diurnal Period: Autonomic Mechanisms
    Michael R. Irwin, Luis Olmos, Minge Wang, Edwin M. Valladares, Sarosh J. Motivala, Tim Fong, Tom Newton, Anthony Butch, Richard Olmstead and Steve W. Cole
    Journal of Pharmacology and Experimental Therapeutics February 2007, 320 (2) 507-515; DOI: https://doi.org/10.1124/jpet.106.112797
  • You have access
    Cucurbitacin R Reduces the Inflammation and Bone Damage Associated with Adjuvant Arthritis in Lewis Rats by Suppression of Tumor Necrosis Factor-α in T Lymphocytes and Macrophages
    José M. Escandell, M. Carmen Recio, Salvador Máñez, Rosa M. Giner, Miguel Cerdá-Nicolás and José Luis Ríos
    Journal of Pharmacology and Experimental Therapeutics February 2007, 320 (2) 581-590; DOI: https://doi.org/10.1124/jpet.106.107003
  • You have access
    Agonist and Antagonist Effects of 15R-Prostaglandin (PG) D2 and 11-Methylene-PGD2 on Human Eosinophils and Basophils
    Chantal Cossette, Sinead E. Walsh, Seongjin Kim, Gue-Jae Lee, John A. Lawson, Sophie Bellone, Joshua Rokach and William S. Powell
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 173-179; DOI: https://doi.org/10.1124/jpet.106.111062
  • You have access
    A p38α Selective Mitogen-Activated Protein Kinase Inhibitor Prevents Periodontal Bone Loss
    Keith L. Kirkwood, Fei Li, Jill E. Rogers, Jodie Otremba, Derek D. Coatney, Jaclynn M. Kreider, Nisha J. D'Silva, Sarvajit Chakravarty, Sundeep Dugar, Linda S. Higgins, Andrew A. Protter and Satyanarayana Medicherla
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 56-63; DOI: https://doi.org/10.1124/jpet.106.112466

Pages

  • Previous
  • Next
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics